These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 28978686)

  • 1. The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.
    Balouz V; Melli LJ; Volcovich R; Moscatelli G; Moroni S; González N; Ballering G; Bisio M; Ciocchini AE; Buscaglia CA; Altcheh J
    J Clin Microbiol; 2017 Dec; 55(12):3444-3453. PubMed ID: 28978686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study.
    Jurado Medina L; Chassaing E; Ballering G; Gonzalez N; Marqué L; Liehl P; Pottel H; de Boer J; Chatelain E; Zrein M; Altcheh J
    Lancet Infect Dis; 2021 Aug; 21(8):1141-1150. PubMed ID: 33836157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of congenital Trypanosoma cruzi infection: A serologic test using Shed Acute Phase Antigen (SAPA) in mother-child binomial samples.
    Volta BJ; Russomando G; Bustos PL; Scollo K; De Rissio AM; Sánchez Z; Cardoni RL; Bua J
    Acta Trop; 2015 Jul; 147():31-7. PubMed ID: 25847262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi.
    Balouz V; Cámara Mde L; Cánepa GE; Carmona SJ; Volcovich R; Gonzalez N; Altcheh J; Agüero F; Buscaglia CA
    Clin Vaccine Immunol; 2015 Mar; 22(3):304-12. PubMed ID: 25589551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An α-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort study.
    Abal M; Balouz V; Lopez R; Giorgi ME; Marino C; Cruz CV; Altcheh J; Buscaglia CA
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011910. PubMed ID: 38236916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lineage-specific rapid diagnostic tests can resolve Trypanosoma cruzi TcII/V/VI ecological and epidemiological associations in the Argentine Chaco.
    Murphy N; Macchiaverna NP; Victoria Cardinal M; Bhattacharyya T; Mertens P; Zeippen N; Gustin Y; Gilleman Q; Gürtler RE; Miles MA
    Parasit Vectors; 2019 Sep; 12(1):424. PubMed ID: 31522683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.
    De Marchi CR; Di Noia JM; Frasch AC; Amato Neto V; Almeida IC; Buscaglia CA
    Clin Vaccine Immunol; 2011 Nov; 18(11):1850-5. PubMed ID: 21880857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.
    Machado-de-Assis GF; Silva AR; Do Bem VA; Bahia MT; Martins-Filho OA; Dias JC; Albajar-Viñas P; Torres RM; Lana M
    Clin Vaccine Immunol; 2012 Aug; 19(8):1283-91. PubMed ID: 22739694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal follow up of serological response in children treated for Chagas disease.
    Moscatelli G; Moroni S; García Bournissen F; González N; Ballering G; Schijman A; Corral R; Bisio M; Freilij H; Altcheh J
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007668. PubMed ID: 31465522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
    Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
    Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive role of polymerase chain reaction in the early diagnosis of congenital Trypanosoma cruzi infection.
    Velázquez EB; Rivero R; De Rissio AM; Malagrino N; Esteva MI; Riarte AR; Ruiz AM
    Acta Trop; 2014 Sep; 137():195-200. PubMed ID: 24892867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a New Strategy for Diagnosis of Congenital Trypanosoma cruzi Infection.
    Abras A; Muñoz C; Ballart C; Berenguer P; Llovet T; Herrero M; Tebar S; Pinazo MJ; Posada E; Martí C; Fumadó V; Bosch J; Coll O; Juncosa T; Ginovart G; Armengol J; Gascón J; Portús M; Gállego M
    J Clin Microbiol; 2017 May; 55(5):1396-1407. PubMed ID: 28202792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
    Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
    Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of detecting specific IgA and IgM with recombinant Trypanosoma cruzi antigens in congenital Chagas' disease.
    Lorca M; Veloso C; Munoz P; Bahamonde MI; Garcia A
    Am J Trop Med Hyg; 1995 Jun; 52(6):512-5. PubMed ID: 7611556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.
    Fabbro DL; Danesi E; Olivera V; Codebó MO; Denner S; Heredia C; Streiger M; Sosa-Estani S
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3312. PubMed ID: 25411847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients.
    Romer G; Bracco LA; Ricci AD; Balouz V; Berná L; Villar JC; Ramsey JM; Nolan MS; Torrico F; Kesper N; Altcheh J; Robello C; Buscaglia CA; Agüero F
    PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011542. PubMed ID: 37556493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.
    Guzmán-Gómez D; López-Monteon A; de la Soledad Lagunes-Castro M; Álvarez-Martínez C; Hernández-Lutzon MJ; Dumonteil E; Ramos-Ligonio A
    Parasit Vectors; 2015 Sep; 8():466. PubMed ID: 26384317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
    de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
    Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.